Gentian Diagnostics
Vær den første som følger denne virksomhed
Gentian Diagnostics is a medical diagnostics company that develops and manufactures in vitro diagnostic reagents for high-throughput analysers. Gentian’s expertise and focus lies within homogenous immunoassays, specifically infections, inflammations, kidney failures and congestive heart failures. The company headquarters and production facilities are located in Moss, Norway, serving the global human and veterinary diagnostics markets through sales and representative offices in key countries.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
Oslo Børs
GENT
Daglig lav / høj pris
-
Markedsværdi
-
Aktieomsætning
-
Volumen
-
Finanskalender
Delårsrapport
29.08.2024
Delårsrapport
31.10.2024
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Vatne Equity AS | 13,7 % | 13,7 % |
Kvantia AS | 10,5 % | 10,5 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
GENT: Groundbreaking assay development for measuring total NT-proBNP levels
Gentian Diagnostics: NT-proBNP successful completion of optimisation phase
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools